8
Clinigen has appointed Paul Carter as Non-Executive Chair of its Board
Clinigen, the global pharmaceutical services Group, has appointed seasoned biopharma executive Paul Carter as Non-Executive Chair of its Board.
This move strengthens the Board as Clinigen advances its strategic transformation and expands its role across the full pharmaceutical life cycle.
Paul brings nearly 30 years of global biopharma leadership experience, having held senior roles at Gilead Sciences, GlaxoSmithKline and SmithKline Beecham. At Gilead, he oversaw global commercial operations and $30 billion in annual…